• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Contilisant,一种用于治疗阿尔茨海默病的四靶小分子药物,具有胆碱酯酶、单胺氧化酶抑制以及 H3R 拮抗作用,同时具有 S1R 激动作用特征。

Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile.

机构信息

Laboratory of Medicinal Chemistry, IQOG, CSIC , C/Juan de la Cierva 3 , 28006 Madrid , Spain.

Laboratório de Neurologia Experimental , Universidade do Extremo Sul Catarinense , Av. Universitária , 1105 Criciúma , Brazil.

出版信息

J Med Chem. 2018 Aug 9;61(15):6937-6943. doi: 10.1021/acs.jmedchem.8b00848. Epub 2018 Jul 18.

DOI:10.1021/acs.jmedchem.8b00848
PMID:29969030
Abstract

Contilisant, a permeable, antioxidant, and neuroprotectant agent, showing high nM affinity at H3R and excellent inhibition of the monoamine oxidases and cholinesterases, is an affine and selective S1R agonist in the nanomolar range, based on the binding affinity and functional experiment, a result confirmed by molecular modeling. In addition, contilisant significantly restores the cognitive deficit induced by Aβ in the radial maze assay in an in vivo Alzheimer's disease test, comparing very favorably with donepezil.

摘要

Contilisant 是一种具有通透性、抗氧化和神经保护作用的物质,对 H3R 的亲和力高达纳摩尔水平,对单胺氧化酶和胆碱酯酶具有优异的抑制作用,同时也是一种亲和且选择性的 S1R 激动剂,其亲和力和功能实验结果均证实了这一点,分子建模也验证了这一结果。此外,在体内阿尔茨海默病测试的放射迷宫试验中,Contilisant 可显著恢复 Aβ 诱导的认知缺陷,与多奈哌齐相比具有很大优势。

相似文献

1
Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism Profile.Contilisant,一种用于治疗阿尔茨海默病的四靶小分子药物,具有胆碱酯酶、单胺氧化酶抑制以及 H3R 拮抗作用,同时具有 S1R 激动作用特征。
J Med Chem. 2018 Aug 9;61(15):6937-6943. doi: 10.1021/acs.jmedchem.8b00848. Epub 2018 Jul 18.
2
Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amine.多能 MAO 和胆碱酯酶抑制剂治疗阿尔茨海默病:杂环取代的烷基和环烷基炔丙胺的合成、药理分析和分子建模。
Eur J Med Chem. 2012 Jun;52:251-62. doi: 10.1016/j.ejmech.2012.03.022. Epub 2012 Mar 30.
3
Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.新型多奈哌齐-吲哚基杂合物作为多效胆碱酯酶/单胺氧化酶抑制剂用于潜在治疗阿尔茨海默病的设计、合成、药理学评价、定量构效关系分析、分子模拟及药物代谢动力学/药物毒性预测
Eur J Med Chem. 2014 Mar 21;75:82-95. doi: 10.1016/j.ejmech.2013.12.028. Epub 2014 Jan 27.
4
Dual inhibitors of cholinesterases and monoamine oxidases for Alzheimer's disease.用于治疗阿尔茨海默病的胆碱酯酶和单胺氧化酶双重抑制剂。
Future Med Chem. 2017 May;9(8):811-832. doi: 10.4155/fmc-2017-0036. Epub 2017 May 15.
5
Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease.具有 sigma-1 亲和力和抑制阿尔茨海默病关键酶的神经原性和神经保护性多奈哌齐-黄酮类化合物。
Eur J Med Chem. 2018 Aug 5;156:534-553. doi: 10.1016/j.ejmech.2018.07.026. Epub 2018 Jul 11.
6
Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.多奈哌齐和 N-[(5-(苄氧基)-1-甲基-1H-吲哚-2-基)甲基]-N-甲基丙-2-炔-1-胺杂合体的合成、生物评价和分子模拟作为治疗阿尔茨海默病的新型多效胆碱酯酶/单胺氧化酶抑制剂。
J Med Chem. 2011 Dec 22;54(24):8251-70. doi: 10.1021/jm200853t. Epub 2011 Nov 15.
7
Rational Design and Multibiological Profiling of Novel Donepezil-Trolox Hybrids against Alzheimer's Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties.新型多奈哌齐-曲拉通杂合体通过胆碱能、抗氧化、神经保护和认知增强特性治疗阿尔茨海默病的合理设计和多生物学特征分析。
ACS Chem Neurosci. 2017 Nov 15;8(11):2496-2511. doi: 10.1021/acschemneuro.7b00257. Epub 2017 Aug 25.
8
Emerging therapeutic potentials of dual-acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases.双重作用的 MAO 和 AChE 抑制剂在阿尔茨海默病和帕金森病中的治疗潜力。
Arch Pharm (Weinheim). 2019 Nov;352(11):e1900177. doi: 10.1002/ardp.201900177. Epub 2019 Sep 3.
9
Inhibition of cholinesterase and monoamine oxidase-B activity by Tacrine-Homoisoflavonoid hybrids.他克林-同型异黄酮杂合体对胆碱酯酶和单胺氧化酶-B 活性的抑制作用。
Bioorg Med Chem. 2013 Dec 1;21(23):7406-17. doi: 10.1016/j.bmc.2013.09.050. Epub 2013 Oct 1.
10
Multitarget-Directed Ligands Combining Cholinesterase and Monoamine Oxidase Inhibition with Histamine H R Antagonism for Neurodegenerative Diseases.针对神经退行性疾病的同时抑制胆碱酯酶、单胺氧化酶和组胺 H₁R 的多靶点导向配体
Angew Chem Int Ed Engl. 2017 Oct 2;56(41):12765-12769. doi: 10.1002/anie.201706072. Epub 2017 Sep 1.

引用本文的文献

1
Generation and validation of a novel multitarget small molecule in glioblastoma.一种新型多靶点小分子在胶质母细胞瘤中的生成与验证
Cell Death Dis. 2025 Apr 4;16(1):250. doi: 10.1038/s41419-025-07569-1.
2
2-{-[ω-(1-Benzylpiperidin-4-yl)alkyl]amino}-6-[(prop-2-yn-1-yl)amino]pyridine-3,5-dicarbonitriles Showing High Affinity for σ Receptors.对σ受体具有高亲和力的2-{-[ω-(1-苄基哌啶-4-基)烷基]氨基}-6-[(2-丙炔-1-基)氨基]吡啶-3,5-二甲腈
Int J Mol Sci. 2025 Jan 31;26(3):1266. doi: 10.3390/ijms26031266.
3
Design, synthesis and evaluation of benzothiazole-derived phenyl thioacetamides as dual inhibitors of monoamine oxidases and cholinesterases.
苯并噻唑衍生的苯基硫代乙酰胺作为单胺氧化酶和胆碱酯酶双重抑制剂的设计、合成与评价
Mol Divers. 2024 Nov 9. doi: 10.1007/s11030-024-11031-3.
4
Prominent Neuroprotective Potential of Indole-2--methylpropargylamine: High Affinity and Irreversible Inhibition Efficiency towards Monoamine Oxidase B Revealed by Computational Scaffold Analysis.吲哚 - 2 - 甲基炔丙胺显著的神经保护潜力:通过计算支架分析揭示其对单胺氧化酶B的高亲和力和不可逆抑制效率
Pharmaceuticals (Basel). 2024 Sep 28;17(10):1292. doi: 10.3390/ph17101292.
5
The allure of targets for novel drugs.新型药物靶点的吸引力。
RSC Med Chem. 2023 Dec 13;15(2):472-484. doi: 10.1039/d3md00621b. eCollection 2024 Feb 21.
6
Conceptual Framework of the Design of Pleiotropic Drugs against Alzheimer's Disease.治疗阿尔茨海默病的多效性药物设计的概念框架。
Pharmaceutics. 2023 Sep 26;15(10):2382. doi: 10.3390/pharmaceutics15102382.
7
8-Hydroxyquinolylnitrones as multifunctional ligands for the therapy of neurodegenerative diseases.8-羟基喹啉硝酮作为治疗神经退行性疾病的多功能配体。
Acta Pharm Sin B. 2023 May;13(5):2152-2175. doi: 10.1016/j.apsb.2023.01.013. Epub 2023 Jan 19.
8
Benzophenone Derivatives with Histamine H Receptor Affinity and Cholinesterase Inhibitory Potency as Multitarget-Directed Ligands for Possible Therapy of Alzheimer's Disease.具有组胺 H 受体亲和力和胆碱酯酶抑制活性的二苯甲酮衍生物作为阿尔茨海默病多靶点治疗的潜在配体。
Molecules. 2022 Dec 28;28(1):238. doi: 10.3390/molecules28010238.
9
The Chemotype of Chromanones as a Privileged Scaffold for Multineurotarget Anti-Alzheimer Agents.作为多神经靶点抗阿尔茨海默病药物的优势骨架的色满酮化学类型
ACS Pharmacol Transl Sci. 2022 Oct 12;5(11):1097-1108. doi: 10.1021/acsptsci.2c00097. eCollection 2022 Nov 11.
10
-Hydroxy--Propargylamide Derivatives of Ferulic Acid: Inhibitors of Cholinesterases and Monoamine Oxidases.阿魏酸羟丙基丙烯酰胺衍生物:胆碱酯酶和单胺氧化酶抑制剂。
Molecules. 2022 Nov 1;27(21):7437. doi: 10.3390/molecules27217437.